Theravectys
Paris
About Theravectys
Theravectys is a development-stage biotechnology company with a novel vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other diseases and conditions. Their first clinical studies will be in HIV/AIDS, using their lead product, a therapeutic vaccine, which has shown promising efficacy and safety in non-human primates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $51.3M
- Last round: Series Unknown (Feb 2021)
- Website: theravectys.com
- Phone: 33 1 44 38 93 13
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/theravectys-61505 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.